Sustained release particle formulations
Particles for delivery of active ingredients formed from an active ingredient and a hydrophobic matrix, as well as methods for making such particles.
1. A composition comprising particles, each particle comprising guaifenesin, a hydrophobic wax matrix, wherein the hydrophobic wax matrix is present in an amount from about 50% to about 70% by weight of the particles, a stabilizer disposed within the hydrophobic wax matrix, wherein the stabilizer is ethyl cellulose and is present in an amount from about 0.1% to about 5% by weight of the particles, and a release modifier, wherein the release modifier is stearic acid and is present in an amount from about 5% to about 25% by weight of the particles; and wherein the particles have a mean particle size diameter of from about 20 μm to about 500 μm.
2. The composition of claim 1 , wherein the particles have a diameter with no more than a 25% standard deviation from the mean particle diameter.
3. The composition of claim 1 , wherein the particles have a diameter with no more than a 15% standard deviation from the mean particle diameter.
4. The composition of claim 1 , wherein the particles have a diameter with no more than a 10% standard deviation from the mean particle diameter.
5. The composition of claim 1 , wherein the particles are characterized by a standard deviation of 10% or less in the release profile at any given time point during the course of dissolution when placed at 40° C. for up to at least 4 weeks as measured by United States Pharmacopeia (USP) II dissolution.
6. The composition of claim 1 , wherein the hydrophobic wax matrix is selected from the group consisting of ceresine wax, beeswax, ozokerite, microcrystalline wax, candelilla wax, montan wax, carnauba wax, paraffin wax, cauassu wax, Japan wax, and Shellac wax.
7. The composition of claim 1 , wherein the particles comprise a layer disposed on the surface of the particle.
8. The composition of claim 1 , further comprising a liquid vehicle.
9. The composition of claim 1 , further comprising a liquid vehicle, wherein the liquid vehicle comprises an active ingredient that is either guaifenesin or a different active ingredient.
10. The composition of claim 1 , wherein the particles are configured to have sustained release of guaifenesin over a period of 1 hour or more.
11. The composition of claim 1 , wherein the particles are configured to have sustained release of guaifenesin over a period of 8 hours or more.
12. The composition of claim 1 , wherein the particles release less than about 45% of guaifenesin in the first hour, about 40-55% of guaifenesin in the second hour, about 62-80% of guaifenesin in the sixth hour, and greater than about 85% of guaifenesin in the twelfth hour.
13. The composition of claim 1 further comprising dextromethorphan.